Latest Insider Transactions at Krystal Biotech, Inc. (KRYS)
This section provides a real-time view of insider transactions for Krystal Biotech, Inc. (KRYS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Krystal Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Krystal Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
SELL
Open market or private sale
|
Direct |
20,000
-77.61%
|
$3,280,000
$164.6 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$440,000
$22.75 P/Share
|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Mar 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.23%
|
$4,275,000
$171.18 P/Share
|
|
Mar 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.22%
|
$4,275,000
$171.04 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,314
-12.9%
|
$377,182
$163.08 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+4.45%
|
$1,050,000
$60.9 P/Share
|
|
Feb 28
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.93%
|
$2,075,000
$166.99 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Indirect |
12,500
+0.76%
|
-
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,471
-0.22%
|
$565,773
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+0.47%
|
-
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,785
-0.35%
|
$942,955
$163.08 P/Share
|
|
Feb 28
2024
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+0.76%
|
-
|
|
Feb 27
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,913
+12.88%
|
$99,476
$52.26 P/Share
|
|
Feb 26
2024
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-0.15%
|
$369,421
$157.0 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,533
-12.21%
|
$240,681
$157.0 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,087
-24.11%
|
$1,107,919
$137.5 P/Share
|
|
Feb 26
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,087
+19.32%
|
$420,524
$52.26 P/Share
|
|
Feb 26
2024
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,791
-0.23%
|
$595,187
$157.0 P/Share
|
|
Jan 22
2024
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,500
-16.6%
|
$325,000
$130.0 P/Share
|
|
Jan 22
2024
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+14.24%
|
$130,000
$52.26 P/Share
|
|
Dec 11
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.38%
|
$2,625,000
$105.92 P/Share
|
|
Dec 11
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.39%
|
$2,625,000
$105.76 P/Share
|
|
Dec 11
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.39%
|
$2,625,000
$105.76 P/Share
|
|
Dec 11
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.38%
|
$2,625,000
$105.92 P/Share
|
|
Sep 11
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.3%
|
$3,175,000
$127.21 P/Share
|
|
Sep 11
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.31%
|
$3,175,000
$127.21 P/Share
|
|
Sep 11
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.31%
|
$3,175,000
$127.21 P/Share
|
|
Sep 11
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.3%
|
$3,175,000
$127.21 P/Share
|
|
Jun 09
2023
|
Andrew C. Orth Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-70.92%
|
$1,600,000
$128.91 P/Share
|
|
Jun 09
2023
|
Andrew C. Orth Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+49.8%
|
$787,500
$63.55 P/Share
|
|
Jun 09
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
18,935
-5.24%
|
$2,423,680
$128.89 P/Share
|
|
Jun 08
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
31,065
-3.58%
|
$3,976,320
$128.25 P/Share
|
|
May 31
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.51%
|
$2,900,000
$116.8 P/Share
|
|
May 31
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.49%
|
$2,900,000
$116.85 P/Share
|
|
May 31
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.49%
|
$2,900,000
$116.85 P/Share
|
|
May 31
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.51%
|
$2,900,000
$116.8 P/Share
|
|
May 22
2023
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
25,000
-22.02%
|
$2,700,000
$108.27 P/Share
|
|
May 22
2023
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.24%
|
$1,350,000
$54.14 P/Share
|
|
May 19
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
50,000
-24.11%
|
$4,750,000
$95.02 P/Share
|
|
May 19
2023
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
28,428
-36.41%
|
$2,700,660
$95.06 P/Share
|
|
May 19
2023
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+30.5%
|
$1,300,000
$52.26 P/Share
|